相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Therapy-induced antitumor vaccination in neuroblastomas by the combined targeting of IL-2 and TNFα
Enrica Balza et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Complete eradication of human B-cell lymphoma xenografts using rituximab in combination with the immunocytokine L19-IL2
Christoph Schliemann et al.
BLOOD (2009)
Comparative immunohistochemistry of L19 and F16 in non-small cell lung cancer and mesothelioma: Two human antibodies investigated in clinical trials in patients with cancer
Marta Pedretti et al.
LUNG CANCER (2009)
Antibody-Mediated Delivery of Interleukin-2 to the Stroma of Breast Cancer Strongly Enhances the Potency of Chemotherapy
Jessica Marlind et al.
CLINICAL CANCER RESEARCH (2008)
Dose translation from animal to human studies revisited
Shannon Reagan-Shaw et al.
FASEB JOURNAL (2008)
An integrated genomic analysis of human glioblastoma Multiforme
D. Williams Parsons et al.
SCIENCE (2008)
Clinical experience with alpha-particle-emitting At-211: Treatment of recurrent brain tumor patients with At-211-labeled chimeric antitenascin monoclonal antibody 81C6
Michael R. Zalutsky et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
Antibody-based targeting of the tumor vasculature
Christoph Schliemann et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2007)
Adenovirally delivered tumor necrosis factor-α- improves the antiglioma efficacy of concomitant radiation and temozolomide therapy
Bakhtiar Yamini et al.
CLINICAL CANCER RESEARCH (2007)
Targeted α-particle radiotherapy with 211At-labeled monoclonal antibodies
Michael R. Zalutsky et al.
NUCLEAR MEDICINE AND BIOLOGY (2007)
The antibody-mediated targeted delivery of interleukin-15 and GM-CSF to the tumor neovasculature inhibits tumor growth and metastasis
Manuela Kaspar et al.
CANCER RESEARCH (2007)
Temozolomide-mediated radiation enhancement in glioblastoma: A report on underlying mechanisms
Arnab Chakravarti et al.
CLINICAL CANCER RESEARCH (2006)
Radioimmunotherapy targeting the extra domain B of fibronectin in C6 rat gliomas: a preliminary study about the therapeutic efficacy of iodine-131-labeled SIP(L19)
Nicolas Spaeth et al.
NUCLEAR MEDICINE AND BIOLOGY (2006)
Radioimmunotherapy of brain tumor
Giovanni Paganelli et al.
NEUROLOGICAL RESEARCH (2006)
Tumor-targeting properties of novel antibodies specific to the large isoform of tenascin-C
Simon S. Brack et al.
CLINICAL CANCER RESEARCH (2006)
Antibody targeted drugs as cancer therapeutics
D Schrama et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Engineered vascular-targeting antibody-interferon-γ fusion protein for cancer therapy
C Ebbinghaus et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
ED-B fibronectin as a target for antibody-based cancer treatments
A Menrad et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Monoclonal antibody therapy of cancer
GP Adams et al.
NATURE BIOTECHNOLOGY (2005)
Vascular targeting agents as cancer therapeutics
PE Thorpe
CLINICAL CANCER RESEARCH (2004)
Combinatorial administration of molecules that simultaneously inhibit angiogenesis and invasion leads to increased therapeutic efficacy in mouse models of malignant glioma
L Bello et al.
CLINICAL CANCER RESEARCH (2004)
Genetic pathways to glioblastoma:: A population-based study
H Ohgaki et al.
CANCER RESEARCH (2004)
Selective targeted delivery of TNFα to tumor blood vessels
L Borsi et al.
BLOOD (2003)
NK cells and the tumour microenvironment: implications for NK-cell function and anti-tumour activity
PA Albertsson et al.
TRENDS IN IMMUNOLOGY (2003)
The hypoxic response of tumors is dependent on their microenvironment
B Blouw et al.
CANCER CELL (2003)
Contrasting effects of interleukin-2 secretion by rat glioma cells contingent upon anatomical location: accelerated tumorigenesis in the central nervous system and complete rejection in the periphery
MR Graf et al.
JOURNAL OF NEUROIMMUNOLOGY (2003)
Differentiation between high- and low-grade astrocytoma using a human recombinant antibody to the extra domain-B of fibronectin
P Castellani et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Selective targeting of tumoral vasculature: Comparison of different formats of an antibody (L19) to the ED-B domain of fibronectin
L Borsi et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Enhancement of the antitumor activity of interleukin-12 by targeted delivery to neovasculature
C Halin et al.
NATURE BIOTECHNOLOGY (2002)
Enhancement of the antitumor properties of interleukin-2 by its targeted delivery to the tumor blood vessel extracellular matrix
B Carnemolla et al.
BLOOD (2002)
Selective expansion and partial activation of human NK cells and NK receptor-positive T cells by IL-2 and IL-15
J Dunne et al.
JOURNAL OF IMMUNOLOGY (2001)
Current and future developments in the use of temozolomide for the treatment of brain tumours
R Stupp et al.
LANCET ONCOLOGY (2001)
Role of nuclear medicine in the treatment of malignant gliomas: the locoregional radioimmunotherapy approach
P Riva et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE (2000)
A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse
WKA Yung et al.
BRITISH JOURNAL OF CANCER (2000)
分享论文
